This report summarizes a discrete-event simulation cost-effectiveness
analysis for one India NICU with 3,300 admissions per year and 5
available bCPAP devices. The model compares No bCPAP to
bCPAP over a 10-year time horizon using 1,000 simulation
runs.
| Metric | Value |
|---|---|
| Admissions per year | 3,300 |
| Simulation horizon (years) | 10 |
| Number of simulation runs | 1,000 |
| bCPAP devices in NICU | 5 |
| Average annual RDS cases | 68.29 |
| Average annual RDS deaths averted | 7.49 |
| Average annual discounted DALYs averted | 164.18 |
| Average annual discounted incremental cost (USD) | 3,748.42 |
| ICER (USD per discounted DALY averted) | 22.83 |
The table below follows the format you provided. In this report, the
comparator is No bCPAP rather than
Nasal Cannula, because the current model only includes
those two strategies. The discounted DALY column is
interpreted as discounted DALYs averted relative to the
No bCPAP comparator.
| Intervention | discounted cost | discounted DALY | ICER |
|---|---|---|---|
| No bCPAP | 60,024.09 | 0.00 | na |
| bCPAP | 97,508.25 | 1,641.79 | 22.83 |
The bCPAP strategy increases average discounted 10-year cost per NICU run from 60,024.09 USD to 97,508.25 USD and generates 1,641.79 discounted DALYs averted, giving an ICER of 22.83 USD per discounted DALY averted.
| Parameter | Value |
|---|---|
| Probability of term birth | 0.85 |
| Relative split of preterm births | Late preterm 85.4%, very preterm 10.4%, extremely preterm 4.2% of all preterm births |
| RDS probability in term births | 0.00333 |
| RDS probability in late preterm births | 0.050 |
| RDS probability in very preterm births | 0.333 |
| RDS probability in extremely preterm births | 0.99 |
| RDS case fatality without bCPAP | 0.235 |
| RDS case fatality with bCPAP | 0.125 |
| India life expectancy at birth (years) | 72 |
| DALY multiplier applied to life expectancy | 0.85 |
| Annual discount rate | 0.03 |
| Supplies cost per treated patient (USD) | 3.21 |
| NICU cost per day (USD) | 25.00 |
| Oxygen cost per liter (USD) | 0.0003 |
| Oxygen liters per treated patient-day | 25,000 |
| Oxygen cost per treated patient-day (USD) | 7.50 |
| Nursing labor minutes per treated patient-day | 15 |
| Nurse annual salary (USD) | 3,000.00 |
| Nurse work hours per year | 2,000 |
| Nurse hourly cost (USD) | 1.50 |
| Nursing labor cost per treated patient-day (USD) | 0.375 |
| Device capital cost (USD) | 500.00 |
| Device useful life (years) | 3 |
| Annualized device cost per device-year (USD) | 166.67 |
0.85 * life expectancy at birth, and those DALYs are
discounted at 3% per year.| Metric | Mean | SD |
|---|---|---|
| Average annual RDS cases | 68.29 | 8.24 |
| Average annual RDS cases treated with bCPAP | 68.05 | 8.12 |
| Average annual RDS cases untreated | 0.24 | 0.58 |
| Average annual deaths averted | 7.49 | 0.89 |
| Average annual discounted DALYs averted | 164.18 | 24.17 |
| Average annual device utilization | 0.224 | 0.028 |
| Average annual oxygen cost (USD) | 3,061.55 | 379.31 |
| Average annual nursing labor cost (USD) | 153.08 | 18.97 |
| Average annual incremental cost (USD) | 4,266.41 | 423.14 |
| Average annual discounted incremental cost (USD) | 3,748.42 | 489.27 |
average_annual_device_utilization is the fraction of
available device-days used in a typical year. With 5 devices, a
utilization of 0.224 means that roughly 1.12 devices are in use on an
average day.